Once A US CDC Critic, Jay Bhattacharya To Lead Agency On Acting Basis

Jay Bhattacharya, a prominent figure who previously criticized the Centers for Disease Control and Prevention (CDC) during the Trump administration, has been appointed as the acting director of the agency. This decision comes amid ongoing debates about public health policies and responses to the COVID-19 pandemic. Bhattacharya, known for his controversial views on lockdowns and his advocacy for focused protection strategies, will now oversee the agency responsible for safeguarding public health in the United States. His appointment may signal a shift in the CDC's approach to managing health crises, as Bhattacharya's past criticisms have highlighted perceived shortcomings in the agency's pandemic response. As the acting director, he faces the challenge of addressing public health concerns while navigating the complex political landscape surrounding health policy. This development is likely to attract significant attention from both supporters and critics of his previous stances, as well as from health experts looking to understand the implications for health governance in the U.S. and beyond.
Originally reported by NDTV World. Read original article
Related Articles
France's Macron accepts resignation of Louvre museum chief after jewel theft
French President Emmanuel Macron has accepted the resignation of Laurence des Cars, the director of the Louvre Museum, f...
CIA offers tips to potential informants in Iran as Trump considers military action
In a significant development, the Central Intelligence Agency (CIA) has begun outreach to potential informants within Ir...
WorldAn Israel visit — its strategic, economic, regional impact
The Prime Minister's upcoming visit to Israel is poised to significantly enhance India's diplomatic and economic ties wi...
Russia opens criminal investigation against Telegram app founder Pavel Durov
Pavel Durov, the founder of the popular messaging platform Telegram, has disclosed that he is the subject of a criminal...